201 related articles for article (PubMed ID: 20146483)
1. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
2. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
Baqi Y; Atzler K; Köse M; Glänzel M; Müller CE
J Med Chem; 2009 Jun; 52(12):3784-93. PubMed ID: 19463000
[TBL] [Abstract][Full Text] [Related]
3. α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors.
Bhattarai S; Freundlieb M; Pippel J; Meyer A; Abdelrahman A; Fiene A; Lee SY; Zimmermann H; Yegutkin GG; Sträter N; El-Tayeb A; Müller CE
J Med Chem; 2015 Aug; 58(15):6248-63. PubMed ID: 26147331
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
5. Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Iqbal J; Saeed A; Raza R; Matin A; Hameed A; Furtmann N; Lecka J; Sévigny J; Bajorath J
Eur J Med Chem; 2013; 70():685-91. PubMed ID: 24215819
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
Ripphausen P; Freundlieb M; Brunschweiger A; Zimmermann H; Müller CE; Bajorath J
J Med Chem; 2012 Jul; 55(14):6576-81. PubMed ID: 22731815
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an ecto-5'-nucleotidase (EC 3.1.3.5) activity in intact trophozoites of Trichomonas gallinae.
Borges FP; Gottardi B; Stuepp C; Larré AB; Tasca T; De Carli GA; Bonan CD
Vet Parasitol; 2007 Jan; 143(2):106-11. PubMed ID: 16962709
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
[TBL] [Abstract][Full Text] [Related]
9. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
[TBL] [Abstract][Full Text] [Related]
10. Identification of small molecule sulfonic acids as ecto-5'-Nucleotidase inhibitors.
Raza R; Saeed A; Lecka J; Sévigny J; Iqbal J
Med Chem; 2012 Nov; 8(6):1133-9. PubMed ID: 22741787
[TBL] [Abstract][Full Text] [Related]
11. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.
Baqi Y; Rashed M; Schäkel L; Malik EM; Pelletier J; Sévigny J; Fiene A; Müller CE
Front Pharmacol; 2020; 11():1282. PubMed ID: 32973513
[TBL] [Abstract][Full Text] [Related]
12. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
[TBL] [Abstract][Full Text] [Related]
14. The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5'-nucleotidase in rat hearts.
Sato T; Obata T; Yamanaka Y; Arita M
Br J Pharmacol; 1997 Oct; 122(4):611-8. PubMed ID: 9375955
[TBL] [Abstract][Full Text] [Related]
15. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
Sadej R; Spychala J; Skladanowski AC
Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268
[TBL] [Abstract][Full Text] [Related]
16. 4-Aminopyridine based amide derivatives as dual inhibitors of tissue non-specific alkaline phosphatase and ecto-5'-nucleotidase with potential anticancer activity.
Hassan S; Ejaz SA; Saeed A; Shehzad M; Ullah Khan S; Lecka J; Sévigny J; Shabir G; Iqbal J
Bioorg Chem; 2018 Feb; 76():237-248. PubMed ID: 29197225
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.
Weyler S; Baqi Y; Hillmann P; Kaulich M; Hunder AM; Müller IA; Müller CE
Bioorg Med Chem Lett; 2008 Jan; 18(1):223-7. PubMed ID: 18006312
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis-based nanoscale assays for monitoring ecto-5'-nucleotidase activity and inhibition in preparations of recombinant enzyme and melanoma cell membranes.
Iqbal J; Jirovsky D; Lee SY; Zimmermann H; Müller CE
Anal Biochem; 2008 Feb; 373(1):129-40. PubMed ID: 17980347
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
